Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' HITZEMANN R' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 82 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Volkow, ND; Chang, L; Wang, GJ; Fowler, JS; Franceschi, D; Sedler, M; Gatley, SJ; Miller, E; Hitzemann, R; Ding, YS; Logan, J
      Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence

      JOURNAL OF NEUROSCIENCE
    2. Fowler, JS; Volkow, ND; Logan, J; Franceschi, D; Wang, GJ; MacGregor, R; Shea, C; Garza, V; Pappas, N; Carter, P; Netusil, N; Bridge, P; Liederman, D; Elkashef, A; Rotrosen, J; Hitzemann, R
      Evidence that L-deprenyl treatment for one week does not inhibit MAO A or the dopamine transporter in the human brain

      LIFE SCIENCES
    3. Thanos, PK; Volkow, ND; Freimuth, P; Umegaki, H; Ikari, H; Roth, G; Ingram, DK; Hitzemann, R
      Overexpression of dopamine D2 receptors reduces alcohol self-administration (vol 78, pg 1094, 2000)

      JOURNAL OF NEUROCHEMISTRY
    4. Thanos, PK; Volkow, ND; Freimuth, P; Umegaki, H; Ikari, H; Roth, G; Ingram, DK; Hitzemann, R
      Overexpression of dopamine D2 receptors reduces alcohol self-administration

      JOURNAL OF NEUROCHEMISTRY
    5. Volkow, ND; Chang, L; Wang, GJ; Fowler, JS; Leonido-Yee, M; Franceschi, D; Sedler, MJ; Gatley, SJ; Hitzemann, R; Ding, YS; Logan, J; Wong, C; Miller, EN
      Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers

      AMERICAN JOURNAL OF PSYCHIATRY
    6. Volkow, ND; Chang, L; Wang, GJ; Fowler, JS; Franceschi, D; Sedler, MJ; Gatley, SJ; Hitzemann, R; Ding, YS; Wong, C; Logan, J
      Higher cortical and lower subcortical metabolism in detoxified methamphetamine abusers

      AMERICAN JOURNAL OF PSYCHIATRY
    7. Volkow, ND; Chang, L; Wang, GJ; Fowler, JS; Ding, YS; Sedler, M; Logan, J; Franceschi, D; Gatley, J; Hitzemann, R; Gifford, A; Wong, C; Pappas, N
      Low level of brain dopamine D-2 receptors in methamphetamine abusers: Association with metabolism in the orbitofrontal cortex

      AMERICAN JOURNAL OF PSYCHIATRY
    8. Belknap, JK; Hitzemann, R; Crabbe, JC; Phillips, TJ; Buck, KJ; Williams, RW
      QTL analysis and genomewide mutagenesis in mice: Complementary genetic approaches to the dissection of complex traits - Commentary

      BEHAVIOR GENETICS
    9. Demarest, K; Koyner, J; McCaughran, J; Cipp, L; Hitzemann, R
      Further characterization and high-resolution mapping of quantitative traitloci for ethanol-induced locomotor activity

      BEHAVIOR GENETICS
    10. Hitzemann, R
      Animal models of psychiatric disorders and their relevance to alcoholism

      ALCOHOL RESEARCH & HEALTH
    11. Hitzemann, R; Demarest, K; Koyner, J; Cipp, L; Patel, N; Rasmussen, E; McCaughran, J
      Effect of genetic cross on the detection of quantitative trait loci and a novel approach to mapping QTLs

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    12. Volkow, ND; Wang, GJ; Fischman, MW; Foltin, R; Fowler, JS; Franceschi, D; Franceschi, M; Logan, J; Gatley, SJ; Wong, C; Ding, YS; Hitzemann, R; Pappas, N
      Effects of route of administration on cocaine induced dopamine transporterblockade in the human brain

      LIFE SCIENCES
    13. Volkow, ND; Wang, GJ; Fowler, JS; Franceschi, D; Thanos, PK; Wong, C; Gatley, SJ; Ding, YS; Molina, P; Schlyer, D; Alexoff, D; Hitzemann, R; Pappas, N
      Cocaine abusers show a blunted response to alcohol intoxication in limbic brain regions

      LIFE SCIENCES
    14. Volkow, ND; Fowler, JS; Logan, J; Gatley, SJ; Wang, GJ; Hitzemann, R
      Measuring dopamine D-2 receptors - Dr. Volkow and colleagues reply

      AMERICAN JOURNAL OF PSYCHIATRY
    15. Volkow, ND; Logan, J; Fowler, JS; Wang, GJ; Gur, RC; Wong, C; Felder, C; Gatley, SJ; Ding, YS; Hitzemann, R; Pappas, N
      Association between age-related decline in brain dopamine activity and impairment in frontal and cingulate metabolism

      AMERICAN JOURNAL OF PSYCHIATRY
    16. Koyner, J; Demarest, K; McCaughran, J; Cipp, L; Hitzemann, R
      Identification and time dependence of quantitative trait loci for basal locomotor activity in the BXD recombinant inbred series and a B6D2 F-2 intercross

      BEHAVIOR GENETICS
    17. Demarest, K; McCaughran, J; Mahjubi, E; Cipp, L; Hitzemann, R
      Identification of an acute ethanol response quantitative trait locus on mouse chromosome 2

      JOURNAL OF NEUROSCIENCE
    18. Hitzemann, B; Hitzemann, R
      Chlordiazepoxide-induced expression of c-Fos in the central extended amygdala and other brain regions of the C57BL/6J and DBA/2J inbred mouse strains: Relationships to mechanisms of ethanol action

      ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
    19. Demarest, K; Hitzemann, B; Phillips, T; Hitzemann, R
      Ethanol-induced expression of c-Fos differentiates the FAST and SLOW selected lines of mice

      ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
    20. Fowler, JS; Volkow, ND; Ding, YS; Wang, GJ; Dewey, S; Fischman, MW; Foltin, R; Hitzemann, R
      Positron emission tomography studies of dopamine-enhancing drugs

      JOURNAL OF CLINICAL PHARMACOLOGY
    21. Volkow, ND; Wang, J; Fowler, JS; Fischman, M; Foltin, R; Abumrad, NN; Gatley, SJ; Logan, J; Wong, C; Gifford, A; Ding, YS; Hitzemann, R; Pappas, N
      Methylphenidate and cocaine have a similar in vivo potency to block dopamine transporters in the human brain

      LIFE SCIENCES
    22. Volkow, ND; Wang, GJ; Fowler, JS; Logan, J; Gatley, SJ; Wong, C; Hitzemann, R; Pappas, NR
      Reinforcing effects of psychostimulants in humans are associated with increases in brain dopamine and occupancy of D-2 receptors

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    23. Rasmussen, E; Cipp, L; Hitzemann, R
      Identification of quantitative trait loci for haloperidol-induced catalepsy on mouse chromosome 14

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    24. Volkow, ND; Wang, GJ; Fowler, JS; Gatley, SJ; Logan, J; Ding, YS; Dewey, SL; Hitzemann, R; Gifford, AN; Pappas, NR
      Blockade of striatal dopamine transporters by intravenous methylphenidate is not sufficient to induce self-reports of "high"

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    25. Adler, LA; Rotrosen, J; Edson, R; Lavori, P; Lohr, J; Hitzemann, R; Raisch, D; Caligiuri, M; Tracy, K
      Vitamin E treatment for tardive dyskinesia

      ARCHIVES OF GENERAL PSYCHIATRY
    26. Volkow, ND; Wang, GJ; Fowler, JS; Logan, J; Gatley, SJ; Gifford, A; Hitzemann, R; Ding, YS; Pappas, N
      Prediction of reinforcing responses to psychostimulants in humans by braindopamine D-2 receptor levels

      AMERICAN JOURNAL OF PSYCHIATRY
    27. Volkow, ND; Wang, GJ; Fowler, JS; Hitzemann, R; Angrist, B; Gatley, SJ; Logan, J; Ding, YS; Pappas, N
      Association of methylphenidate-induced craving with changes in right striato-orbitofrontal metabolism in cocaine abusers: Implications in addiction

      AMERICAN JOURNAL OF PSYCHIATRY
    28. McCaughran, J; Bell, J; Hitzemann, R
      On the relationships of high-frequency hearing loss and cochlear pathologyto the acoustic startle response (ASR) and prepulse inhibition of the ASR in the BXD recombinant inbred series

      BEHAVIOR GENETICS
    29. Hitzemann, R; Cipp, L; Demarest, K; Mahjubi, E; McCaughran, J
      Genetics of ethanol-induced locomotor activation: detection of QTLs in a C57BL/6JxDBA/2JF(2) intercross

      MAMMALIAN GENOME
    30. VOLKOW ND; WANG GJ; FOWLER JS; HITZEMANN R; GATLEY J; DING YS; WONG C; PAPPAS N
      DIFFERENCES IN REGIONAL BRAIN METABOLIC RESPONSES BETWEEN SINGLE AND REPEATED DOSES OF METHYLPHENIDATE

      PSYCHIATRY RESEARCH-NEUROIMAGING
    31. PATEL N; HITZEMANN B; HITZEMANN R
      GENETICS, HALOPERIDOL, AND THE FOS RESPONSE IN THE BASAL GANGLIA - A COMPARISON OF THE C57BL 6J AND DBA/2J INBRED MOUSE STRAINS/

      Neuropsychopharmacology
    32. VOLKOW ND; WANG GJ; FOWLER JS; DING YS; GUR RC; GATLEY J; LOGAN J; MOBERG PJ; HITZEMANN R; SMITH G; PAPPAS N
      PARALLEL LOSS OF PRESYNAPTIC AND POSTSYNAPTIC DOPAMINE MARKERS IN NORMAL AGING

      Annals of neurology
    33. DEMAREST K; HITZEMANN B; MAHJUBI E; MCCAUGHRAN J; HITZEMANN R
      FURTHER EVIDENCE THAT THE CENTRAL NUCLEUS OF THE AMYGDALA IS ASSOCIATED WITH THE ETHANOL-INDUCED LOCOMOTOR RESPONSE

      Alcoholism, clinical and experimental research
    34. VOLKOW ND; GUR RC; WANG GJ; FOWLER JS; MOBERG PJ; DING YS; HITZEMANN R; SMITH G; LOGAN J
      ASSOCIATION BETWEEN DECLINE IN BRAIN DOPAMINE ACTIVITY WITH AGE AND COGNITIVE AND MOTOR IMPAIRMENT IN HEALTHY-INDIVIDUALS

      The American journal of psychiatry
    35. VOLKOW ND; WANG GJ; FOWLER JS; HITZEMANN R; GATLEY SJ; DEWEY SS; PAPPAS N
      ENHANCED SENSITIVITY TO BENZODIAZEPINES IN ACTIVE COCAINE-ABUSING SUBJECTS - A PET STUDY

      The American journal of psychiatry
    36. VOLKOW ND; WANG GJ; FOWLER JS; GATLEY SJ; LOGAN J; DING YS; HITZEMANN R; PAPPAS N
      DOPAMINE TRANSPORTER OCCUPANCIES IN THE HUMAN BRAIN INDUCED BY THERAPEUTIC DOSES OF ORAL METHYLPHENIDATE

      The American journal of psychiatry
    37. KLINE L; DECENA E; HITZEMANN R; MCCAUGHRAN J
      ACOUSTIC STARTLE, PREPULSE INHIBITION, LOCOMOTION, AND LATENT INHIBITION IN THE NEUROLEPTIC-RESPONSIVE (NR) AND NEUROLEPTIC-NONRESPONSIVE (NNR) LINES OF MICE

      Psychopharmacology
    38. HITZEMANN R; MCCAUGHRAN J; KLINE L; FOCHTMAN L; MAHJUBI I
      GENETICS, HALOPERIDOL-INDUCED CATALEPSY AND HALOPERIDOL EFFECTS ON PREPULSE INHIBITION OF ACOUSTIC STARTLE

      Schizophrenia research
    39. HIRSCHOWITZ J; HITZEMANN R; PISCANI K; BURR G; FRECSKA E; CULLITON D; MANN M; CURTIS C
      THE DOSE REDUCTION IN SCHIZOPHRENIA (DORIS) STUDY - A FINAL REPORT

      Schizophrenia research
    40. LOGAN J; VOLKOW ND; FOWLER JS; WANG GJ; FISCHMAN MW; FOLTIN RW; ABUMRAD NN; VITKUN S; GATLEY SJ; PAPPAS N; HITZEMANN R; SHEA CE
      CONCENTRATION AND OCCUPANCY OF DOPAMINE TRANSPORTERS IN COCAINE ABUSERS WITH [C-11] COCAINE AND PET

      Synapse
    41. VOLKOW ND; WANG GJ; FOWLER JS; LOGAN J; GATLEY SJ; HITZEMANN R; CHEN A; PAPPAS N
      DECREASED STRIATAL AND ENHANCED THALAMIC DOPAMINERGIC RESPONSIVITY INDETOXIFIED COCAINE ABUSERS

      The Journal of nuclear medicine
    42. VOLKOW ND; WANG GJ; FOWLER JS; HITZEMANN R; PAPPAS N
      ENHANCED REGIONAL BRAIN METABOLIC RESPONSES TO BENZODIAZEPINES IN COCAINE ABUSERS

      The Journal of nuclear medicine
    43. RASSMUSSEN E; CIPP L; PATEL V; MAHJUBI E; HITZEMANN R
      HALOPERIDOL-INDUCED CATALEPSY AS A MURINE MODEL OF EXTRAPYRAMIDAL SYMPTOMS MAPS TO CHROMOSOME-9 AND CHROMOSOME-14 IN A BALB C X LP/JF(2) CROSS/

      American journal of medical genetics
    44. HITZEMANN B; HITZEMANN R
      GENETICS, ETHANOL AND THE FOS RESPONSE - A COMPARISON OF THE C57BL 6JAND DBA/2J INBRED MOUSE STRAINS/

      Alcoholism, clinical and experimental research
    45. VOLKOW ND; WANG GJ; OVERALL JE; HITZEMANN R; FOWLER JS; PAPPAS N; FRECSKA E; PISCANI K
      REGIONAL BRAIN METABOLIC RESPONSE TO LORAZEPAM IN ALCOHOLICS DURING EARLY AND LATE ALCOHOL DETOXIFICATION

      Alcoholism, clinical and experimental research
    46. TRACY K; ADLER LA; ROTROSEN J; EDSON R; LAVORI P; GOWDA S; MUKHERJEE S; WILLIAMS B; DUNCAN E; SCHWARTZ M; HITZEMANN R; FRECSKA E; MANICONE P; CAROFF S; CAMPBELL C; HAVEY J; CASEY D; HOFFMAN W; HANSEN T; BRUNDAGE T; HIXS M; HANNA M; LOHR J; BROWNING J; KANOF P; FAIN R; KRYSTAL J; DSOUZA DC; DAMON D; MARDER SS; AMES D; ROSS D; DOORACK J; ADLER L; ROTROSEN J; HITZEMANN R; LOHR J; EDSON R; HAAKENSON C; MILLER M
      INTERRATER RELIABILITY ISSUES IN MULTICENTER TRIALS .1. THEORETICAL CONCEPTS AND OPERATIONAL PROCEDURES USED IN DEPARTMENT-OF-VETERANS-AFFAIRS COOPERATIVE STUDY NUMBER-3941

      Psychopharmacology bulletin
    47. EDSON R; LAVORI P; TRACY K; ADLER LA; ROTROSEN J; GOWDA S; MUKHERJEE S; WILLIAMS B; DUNCAN E; VAID G; SCHWARTZ M; HITZEMANN R; FRECSKA E; MANICONE P; CAROFF S; CAMPBELL EC; HAVEY J; CASEY D; HOFFMAN W; HANSEN T; BRUNDAGE T; HIXS M; HANNA M; LOHR J; BROWNING J; KANOF P; FAIN R; KRYSTAL J; DSOUZA DC; DAMON D; MARDER S; AMES D; ROSS D; DOORACK J; ADLER L; ROTROSEN J; HITZEMANN R; LOHR J; HAAKENSON C; MILLER M
      INTERRATER RELIABILITY ISSUES IN MULTICENTER TRIALS .2. STATISTICAL PROCEDURES USED IN DEPARTMENT-OF-VETERANS-AFFAIRS COOPERATIVE STUDY NUMBER-3941

      Psychopharmacology bulletin
    48. VOLKOW ND; WANG GJ; FISCHMAN MW; FOLTIN RW; FOWLER JS; ABUMRAD NN; VITKUN S; LOGAN J; GATLEY SJ; PAPPAS N; HITZEMANN R; SHEA CE
      RELATIONSHIP BETWEEN SUBJECTIVE EFFECTS OF COCAINE AND DOPAMINE TRANSPORTER OCCUPANCY

      Nature
    49. VOLKOW ND; WANG GJ; FOWLER JS; LOGAN J; GATLEY SJ; HITZEMANN R; CHEN AD; DEWEY SL; PAPPAS N
      DECREASED STRIATAL DOPAMINERGIC RESPONSIVENESS IN DETOXIFIED COCAINE-DEPENDENT SUBJECTS

      Nature
    50. HIRSCHOWITZ J; HITZEMANN R; VALLABHAJOSULA S
      SPECT STUDIES OF D-2 OCCUPANCY IN LOW-DOSE HALOPERIDOL TREATMENT

      The American journal of psychiatry
    51. VOLKOW ND; WANG GJ; FOWLER JS; LOGAN J; ANGRIST B; HITZEMANN R; LIEBERMAN J; PAPPAS N
      EFFECTS OF METHYLPHENIDATE ON REGIONAL BRAIN GLUCOSE-METABOLISM IN HUMANS - RELATIONSHIP TO DOPAMINE D-2 RECEPTORS

      The American journal of psychiatry
    52. VOLKOW ND; WANG GJ; FOWLER JS; HITZEMANN R; PAPPAS N; PASCANI K; WONG C
      GENDER DIFFERENCES IN CEREBELLAR METABOLISM - TEST-RETEST REPRODUCIBILITY

      The American journal of psychiatry
    53. MCCAUGHRAN J; MAHJUBI E; DECENA E; HITZEMANN R
      GENETICS, HALOPERIDOL-INDUCED CATALEPSY AND HALOPERIDOL-INDUCED CHANGES IN ACOUSTIC STARTLE AND PREPULSE INHIBITION

      Psychopharmacology
    54. VOLKOW ND; WANG GJ; FOWLER JS; LOGAN J; GATLEY SJ; MACGREGOR RR; SCHLYER DJ; HITZEMANN R; WOLF AP
      MEASURING AGE-RELATED-CHANGES IN DOPAMINE D-2 RECEPTORS WITH C-11 RACLOPRIDE AND F-18 N-METHYLSPIROPERIDOL

      PSYCHIATRY RESEARCH-NEUROIMAGING
    55. VOLKOW ND; WANG GJ; FOWLER JS; LOGAN J; HITZEMANN R; GATLEY SJ; MACGREGOR RR; WOLF AP
      COCAINE UPTAKE IS DECREASED IN THE BRAIN OF DETOXIFIED COCAINE ABUSERS

      Neuropsychopharmacology
    56. VOLKOW ND; WANG GJ; FOWLER JS; LOGAN J; DING YS; GATLEY J; HITZEMANN R; PAPPAS N
      DECREASES IN DOPAMINE-RECEPTORS BUT NOT IN DOPAMINE TRANSPORTERS IN ALCOHOLICS

      The Journal of nuclear medicine
    57. VOLKOW ND; WANG GJ; FOWLER JS; GATLEY SJ; DING YS; LOGAN J; HITZEMANN R; PAPPAS N; LIBERMAN J
      RELATIONSHIP BETWEEN DOPAMINE TRANSPORTER OCCUPANCY AND METHYLPHENIDATE INDUCED HIGH IN HUMANS

      The Journal of nuclear medicine
    58. VOLKOW ND; DING YS; FOWLER JS; WANG GJ; LOGAN J; GATLEY SJ; HITZEMANN R; SMITH G; FIELDS SD; GUR R
      DOPAMINE TRANSPORTERS DECREASE WITH AGE

      The Journal of nuclear medicine
    59. VOLKOW ND; WANG GJ; FOWLER JS; LOGAN J; HITZEMANN R; DING YS; PAPPAS N; SHEA C; PISCANI K
      DECREASES IN DOPAMINE-RECEPTORS BUT NOT IN DOPAMINE TRANSPORTERS IN ALCOHOLICS

      Alcoholism, clinical and experimental research
    60. VOLKOW ND; WANG GJ; FOWLER JS; GATLEY SJ; DING YS; LOGAN J; DEWEY SL; HITZEMANN R; LIEBERMAN J
      RELATIONSHIP BETWEEN PSYCHOSTIMULANT-INDUCED HIGH AND DOPAMINE TRANSPORTER OCCUPANCY

      Proceedings of the National Academy of Sciences of the United Statesof America
    61. DAINS K; HITZEMANN B; HITZEMANN R
      GENETICS, NEUROLEPTIC RESPONSE AND THE ORGANIZATION OF CHOLINERGIC NEURONS IN THE MOUSE STRIATUM

      The Journal of pharmacology and experimental therapeutics
    62. KANES S; DAINS K; CIPP L; GATLEY J; HITZEMANN B; RASMUSSEN E; SANDERSON S; SILVERMAN M; HITZEMANN R
      MAPPING THE GENES FOR HALOPERIDOL-INDUCED CATALEPSY

      The Journal of pharmacology and experimental therapeutics
    63. VOLKOW ND; FOWLER JS; WANG GJ; HITZEMANN R; LIEBERMAN J; ANGRIST B
      DOPAMINERGIC MODULATION OF FRONTAL ACTIVITY - INVOLVEMENT IN COCAINE ADDICTION

      Biological psychiatry
    64. HITZEMANN R; CIPP L; RASMUSSEN E; MAHJUBI F
      MAPPING THE GENES FOR HALOPERIDOL RESPONSE

      Behavior genetics
    65. VOLKOW ND; WANG GJ; GATLEY SJ; FOWLER JS; DING YS; LOGAN J; HITZEMANN R; ANGRIST B; LIEBERMAN J
      TEMPORAL RELATIONSHIPS BETWEEN THE PHARMACOKINETICS OF METHYLPHENIDATE IN THE HUMAN BRAIN AND ITS BEHAVIORAL AND CARDIOVASCULAR EFFECTS

      Psychopharmacology
    66. VOLKOW ND; WANG GJ; HITZEMANN R; FOWLER JS; PAPPAS N; LOWRIMORE P; BURR G; PASCANI K; OVERALL J; WOLF AP
      DEPRESSION OF THALAMIC METABOLISM BY LORAZEPAM IS ASSOCIATED WITH SLEEPINESS

      Neuropsychopharmacology
    67. VOLKOW ND; WANG GJ; BEGLEITER H; HITZEMANN R; PAPPAS N; BURR G; PASCANI K; WONG C; FOWLER JS; WOLF AP
      REGIONAL BRAIN METABOLIC RESPONSE TO LORAZEPAM IN SUBJECTS AT RISK FOR ALCOHOLISM

      Alcoholism, clinical and experimental research
    68. VOLKOW ND; DING YS; FOWLER JS; WANG GJ; LOGAN J; GATLEY JS; DEWEY S; ASHBY C; LIEBERMANN J; HITZEMANN R; WOLF AP
      IS METHYLPHENIDATE LIKE COCAINE - STUDIES ON THEIR PHARMACOKINETICS AND DISTRIBUTION IN THE HUMAN BRAIN

      Archives of general psychiatry
    69. VOLKOW ND; WANG GJ; FOWLER JS; LOGAN J; SCHLYER D; HITZEMANN R; LIEBERMAN J; ANGRIST B; PAPPAS N; MACGREGOR R; BURR G; COOPER T; WOLF AP
      IMAGING ENDOGENOUS DOPAMINE COMPETITION WITH [C-11] RACLOPRIDE IN THEHUMAN BRAIN

      Synapse
    70. VOLKOW ND; FOWLER JS; WANG GJ; LOGAN J; SCHLYER D; MACGREGOR R; HITZEMANN R; WOLF AP
      DECREASED DOPAMINE TRANSPORTERS WITH AGE IN HEALTHY-HUMAN SUBJECTS

      Annals of neurology
    71. LOGAN J; VOLKOW ND; FOWLER JS; WANG GJ; DEWEY SL; MACGREGOR R; SCHLYER D; GATLEY SJ; PAPPAS N; KING P; HITZEMANN R; VITKUN S
      EFFECTS OF BLOOD-FLOW ON [C-11] RACLOPRIDE BINDING IN THE BRAIN - MODEL SIMULATIONS AND KINETIC-ANALYSIS OF PET DATA

      Journal of cerebral blood flow and metabolism
    72. KNOLKER HJ; HITZEMANN R
      IMIDAZOLE DERIVATIVES .9. SELECTIVE REACTIONS OF FUNCTIONALIZED IMIDAZO[1,2-A]PYRIDINES - STEREOSPECIFIC SYNTHESIS OF 5,6-DIHYDROIMIDAZO[1,2-A]PYRIDINES

      Tetrahedron letters
    73. HITZEMANN B; DAINS K; KANES S; HITZEMANN R
      FURTHER-STUDIES ON THE RELATIONSHIP BETWEEN DOPAMINE CELL-DENSITY ANDHALOPERIDOL-INDUCED CATALEPSY

      The Journal of pharmacology and experimental therapeutics
    74. HIRSCHOWITZ J; VALLABHAJOSULA S; INTRATOR J; HITZEMANN R; DACOSTA M; MACHAC J
      ANTIPSYCHOTIC DRUG-THERAPY IN SCHIZOPHRENICS - STUDIES OF RECEPTOR OCCUPANCY

      Biological psychiatry
    75. VOLKOW ND; WANG GJ; HITZEMANN R; FOWLER JS; OVERALL JE; BURR G; WOLF AP
      RECOVERY OF BRAIN GLUCOSE-METABOLISM IN DETOXIFIED ALCOHOLICS

      The American journal of psychiatry
    76. VOLKOW ND; FOWLER JS; WANG GJ; HITZEMANN R; LOGAN J; SCHLYER DJ; DEWEY SL; WOLF AP
      DECREASED DOPAMINE-D(2) RECEPTOR AVAILABILITY IS ASSOCIATED WITH REDUCED FRONTAL METABOLISM IN COCAINE ABUSERS

      Synapse
    77. VOLKOW ND; FOWLER JS; WANG GJ; SCHLYER D; LOGAN J; DEWEY SL; HITZEMANN R; ANGRIST B; LIEBERMANN J; MACGREGOR RR; WOLF AP
      SENSITIVITY OF PET MEASUREMENTS WITH C-11 RACLOPRIDE TO CHANGES IN ENDOGENOUS DOPAMINE

      The Journal of nuclear medicine
    78. VOLKOW ND; FOWLER JS; WANG GJ; HITZEMANN R; WOLF AP; LOGAN J; SCHLYER D; MACGREGOR RR; ANGRIST B; LIEBERMANN J; BURR G; PAPPAS N
      PET STUDIES OF THE FUNCTION OF THE DOPAMINE TRANSPORTER IN COCAINE ABUSERS

      The Journal of nuclear medicine
    79. VOLKOW ND; WANG GJ; HITZEMANN R; FOWLER JS; BURR G; PAPPAS N; WOLF AP
      EFFECTS OF ALCOHOL DETOXIFICATION ON REGIONAL BRAIN GLUCOSE-METABOLISM

      The Journal of nuclear medicine
    80. MCNEISH CS; SVINGOS AL; HITZEMANN R; STRECKER RE
      THE 5-HT(3) ANTAGONIST ZACOPRIDE ATTENUATES COCAINE-INDUCED INCREASESIN EXTRACELLULAR DOPAMINE IN RAT NUCLEUS-ACCUMBENS

      Pharmacology, biochemistry and behavior
    81. QIAN YF; HITZEMANN B; YOUNT GL; WHITE JD; HITZEMANN R
      D(1) AND D(2) DOPAMINE-RECEPTOR TURNOVER AND D(2) MESSENGER-RNA LEVELS IN THE NEUROLEPTIC-RESPONSIVE AND THE NEUROLEPTIC NONRESPONSIVE LINES OF MICE

      The Journal of pharmacology and experimental therapeutics
    82. HITZEMANN R; QIAN Y; HITZEMANN B
      DOPAMINE AND ACETYLCHOLINE CELL-DENSITY IN THE NEUROLEPTIC RESPONSIVE(NR) AND NEUROLEPTIC NONRESPONSIVE (NNR) LINES OF MICE

      The Journal of pharmacology and experimental therapeutics


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 22/02/20 alle ore 21:22:56